Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer

Aliabadi, Ali; Khanniri, Elham; Mahboubi-Rabbani, Mohammad; Bayanati, Maryam

doi:10.1016/j.ejmech.2023.115866

European Journal of Medicinal Chemistry

2023

DOI: 10.1016/j.ejmech.2023.115866

|View full text |Cite

Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer

Ali Aliabadi,

Elham Khanniri,

Mohammad Mahboubi-Rabbani

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 10 publications

References 173 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study

Hegazy,

Taher,

Ghiaty

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study

Hegazy,

Taher,

Ghiaty

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

Combining lavendustin C and 5-arylidenethiazolin-4-one-based pharmacophores toward multitarget anticancer hybrids

Othman,

Abou-Ghadir,

Menon

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors

Huang,

Wang,

Huang

et al. 2024

Journal of Molecular Structure

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer

Cited by 10 publications

References 173 publications

Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study

Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study

Combining lavendustin C and 5-arylidenethiazolin-4-one-based pharmacophores toward multitarget anticancer hybrids

Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors

Contact Info

Product

Resources

About